Risk of bleeding after kidney biopsy is not increased in individuals with amyloidosis

  • Published 2008 in Nature Clinical Practice Nephrology


The proportion of patients with type 2 diabetes who are on dialysis is steadily increasing. Early treatment of chronic kidney disease (CKD) delays the onset of end-stage renal disease in these individuals; therefore, the identification of risk factors for CKD is imperative. Targher et al. investigated whether nonalcoholic fatty liver disease (NAFLD), which… (More)
DOI: 10.1038/ncpneph0948